On Tuesday, Tulane University began administering the first doses of the Pfizer/BioNTech vaccine to faculty, staff and students of some of its schools.

Tulane University has been designated as a COVID-19 vaccine provider site by the Louisiana Department of Health and will become one of the first universities in the state to begin administering doses of COVID-19 vaccine. The designation allows Tulane to receive vaccines directly from manufacturers and rapidly mobilize staff to provide immunizations for those in the university community who are eligible under state guidelines. 

Reopening K-12 schools in the United States did not result in an increase in hospitalizations  — in most cases —  due to COVID-19, according to a new study by the National Center for Research on Education Access and Choice (REACH) at Tulane University. 

Tulane doctors were some of the first physicians in the country to receive the COVID-19 vaccine on Wednesday, Dec. 16, following the U.S. Food and Drug Administration’s emergency use authorization for the vaccine on Dec. 11.  

Researchers from Tulane University have developed a 15-minute COVID-19 test that is read by a smartphone to address the need to expand testing capacity in community-based settings.

Tulane University School of Medicine will virtually host “COVID-19 Vaccines: A Community Town Hall” Monday evening at 5:30 p.m. CT to discuss the COVID-19 vaccines.

The National Institutes of Health has awarded a $1 million grant to Tulane University to launch an outreach initiative to reach ethnic and racial minority communities in Louisiana that are disproportionately affected by the COVID-19 pandemic.